Skip to main content
Journal ArticleOPEN ACCESS

Human recombinant soluble ACE2 in severe COVID-19

The Lancet Respiratory Medicine (2020) 8(11) 1154-1158
DOI: 10.1016/S2213-2600(20)30418-5
305Citations
Citations of this article
288Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Cite

CITATION STYLE

APA

Zoufaly, A., Poglitsch, M., Aberle, J. H., Hoepler, W., Seitz, T., Traugott, M., … Penninger, J. M. (2020). Human recombinant soluble ACE2 in severe COVID-19. The Lancet Respiratory Medicine, 8(11), 1154–1158. https://doi.org/10.1016/S2213-2600(20)30418-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free